Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuankai Shi

Showing results (71-80 of 347) with videos related to

Pageof 35
Sort By:
Analytical and Bioanalytical Chemistry|January 11, 2014
Development and validation of a UPLC-MS/MS assay for the quantification of simotinib in human plasmaNing Li, Xiaohong Han, Ping Du, et al.
Current Cancer Drug Targets|April 17, 2015
An Integrative Analysis of the Putative Gefitinib-resistance Related Genes in a Lung Cancer Cell Line Model SystemXiaohong Han, Manjiao Liu, Shuai Wang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 21, 2016
A phase I trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancerXingsheng Hu, Lin Wang, Lin Lin, et al.
Thoracic Cancer|February 27, 2023
Efficacy and safety of osimertinib plus anlotinib in advanced non-small-cell lung cancer patients after drug resistanceMingzhao Wang, Jun Zhao, Tong Chen, et al.
Hepatology (Baltimore, Md.)|October 29, 2024
The co-location of MARCO+ tumor-associated macrophages and CTSE+ tumor cells determined the poor prognosis in intrahepatic cholangiocarcinomaGuangyu Fan, Changcheng Tao, Lin Li, et al.
Journal of Hematology & Oncology|January 16, 2019
Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumorsYongkun Sun, Lin Yang, Xuezhi Hao, et al.
Life Sciences|December 30, 2019
Whole-genome sequencing of prostate cancer reveals novel mutation-driven processes and molecular subgroupsCaixia Liang, Lijuan Niu, Zejun Xiao, et al.
Molecular and Clinical Oncology|March 21, 2014
Sorafenib in metastatic radioactive iodine-refractory differentiated thyroid cancer: A pilot studyYang Luo, Yuankai Shi, Puyuan Xing, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 27, 2014
Development and validation of an ultrafiltration-UPLC-MS/MS method for rapid quantification of unbound docetaxel in human plasmaPing Du, Xiaohong Han, Ning Li, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Spatial transcriptomics reveals prognostically LYZ<sup>+</sup> fibroblasts and colocalization with FN1<sup>+</sup> macrophages in diffuse large B-cell lymphomaLiyuan Dai, Ning Lou, Liling Huang, et al.
Pageof 35

Showing results (71-80 of 347) with videos related to

Sort By:
Pageof 35
Analytical and Bioanalytical Chemistry|January 11, 2014
Development and validation of a UPLC-MS/MS assay for the quantification of simotinib in human plasmaNing Li, Xiaohong Han, Ping Du, et al.
Current Cancer Drug Targets|April 17, 2015
An Integrative Analysis of the Putative Gefitinib-resistance Related Genes in a Lung Cancer Cell Line Model SystemXiaohong Han, Manjiao Liu, Shuai Wang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 21, 2016
A phase I trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancerXingsheng Hu, Lin Wang, Lin Lin, et al.
Thoracic Cancer|February 27, 2023
Efficacy and safety of osimertinib plus anlotinib in advanced non-small-cell lung cancer patients after drug resistanceMingzhao Wang, Jun Zhao, Tong Chen, et al.
Hepatology (Baltimore, Md.)|October 29, 2024
The co-location of MARCO+ tumor-associated macrophages and CTSE+ tumor cells determined the poor prognosis in intrahepatic cholangiocarcinomaGuangyu Fan, Changcheng Tao, Lin Li, et al.
Journal of Hematology & Oncology|January 16, 2019
Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumorsYongkun Sun, Lin Yang, Xuezhi Hao, et al.
Life Sciences|December 30, 2019
Whole-genome sequencing of prostate cancer reveals novel mutation-driven processes and molecular subgroupsCaixia Liang, Lijuan Niu, Zejun Xiao, et al.
Molecular and Clinical Oncology|March 21, 2014
Sorafenib in metastatic radioactive iodine-refractory differentiated thyroid cancer: A pilot studyYang Luo, Yuankai Shi, Puyuan Xing, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 27, 2014
Development and validation of an ultrafiltration-UPLC-MS/MS method for rapid quantification of unbound docetaxel in human plasmaPing Du, Xiaohong Han, Ning Li, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Spatial transcriptomics reveals prognostically LYZ<sup>+</sup> fibroblasts and colocalization with FN1<sup>+</sup> macrophages in diffuse large B-cell lymphomaLiyuan Dai, Ning Lou, Liling Huang, et al.
Pageof 35